GlassScriptPhysician profile
Kyle V Panzer
NPI 1790246916
$776.60
in general payments reported to CMS, 2019-2025
11 companies · $388 in 2025
The $388 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $24.98 · 2022: $64.66 · 2023: $182 · 2024: $118 · 2025: $388.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $687.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $686.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $124.92 | 2025 | Therasphere Y90 Glass Microspheres 10 Gbq |
| Merck Sharp & Dohme LLC | $119.38 | 2023-2024 | Keytruda, Welireg, Lynparza |
| Seagen INC. | $114.86 | 2022-2023 | Padcev |
| Balt USA, LLC | $94.85 | 2025 | Revere Hybrid Access Catheter |
| Terumo Medical Corporation | $91.74 | 2024-2025 | Azur Cx Detachable, Navicross |
| Stryker Corporation | $65.60 | 2025 | Venacore Thrombectomy Catheter, Artix Mt |
| E.R. Squibb & Sons, L.L.C. | $46.33 | 2023 | Opdivo |
| Glaxosmithkline, LLC. | $34.70 | 2022 | |
| Eisai INC. | $31.10 | 2025 | |
| Bard Peripheral Vascular, INC. | $28.14 | 2024 | Trek |
| Incyte Corporation | $24.98 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Panzer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.